Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis

Objectives: The dysregulated immune response occurring upon COVID-19 infection can lead to tissue damage and organ failure. Different therapeutic strategies are needed to cope with the current and future outspread of COVID-19, including antiviral and anti-inflammatory agents. We describe the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastroianni, Antonio, Vangeli, Valeria, Chidichimo, Luciana, Urso, Filippo, De Marco, Giuseppe, Zanolini, Alfredo, Greco, Francesca, Mauro, Maria V, Greco, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402280/
https://www.ncbi.nlm.nih.gov/pubmed/37534444
http://dx.doi.org/10.1177/03946320231189993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402280/
https://www.ncbi.nlm.nih.gov/pubmed/37534444
http://dx.doi.org/10.1177/03946320231189993

Ejemplares similares